-+ 0.00%
-+ 0.00%
-+ 0.00%

NMPA ACCEPTS NEW INDICATION APPLICATION FOR SACITUZUMAB TIRUMOTECAN (SAC-TMT) AS FIRST-LINE TREATMENT FOR ADVANCED TNBC

Reuters·07/30/2026 09:10:22

Please log in to view news